Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;22(2):72-74.
doi: 10.1093/pch/pxx002. Epub 2017 Apr 4.

Diagnosis and management of infants with congenital cytomegalovirus infection

Soren Gantt  1 , Ari Bitnun  2 , Christian Renaud  3 , Fatima Kakkar  3 , Wendy Vaudry  4
Affiliations

Diagnosis and management of infants with congenital cytomegalovirus infection

Soren Gantt et al. Paediatr Child Health. 2017 May.

Abstract

Congenital cytomegalovirus infection (cCMV) is the most common congenital infection, occurring in approximately 0.5% of live births. Most infected newborns are asymptomatic, but up to 20% develop sensorineural hearing loss or other permanent neurologic sequelae. The presentation of newborns with symptomatic cCMV is highly variable, and the infection is usually not diagnosed in the absence of a screening program. Newborn cCMV screening programs are estimated to be beneficial and cost-effective, and are increasingly being implemented. Diagnosis requires direct detection of virus in a sample obtained before 3 weeks of life, and is best performed by polymerase chain reaction (PCR) of saliva or urine, either of which is more sensitive than dried blood spot. Antiviral treatment of selected newborns with cCMV-related disease appears to improve hearing and neurocognitive outcomes. All infected infants should be evaluated promptly to determine appropriate therapy, and receive close audiologic and developmental follow-up.

Keywords: Childhood hearing loss; Congenital cytomegalovirus infection; Diagnosis; Newborn screening.; Treatment.

PubMed Disclaimer

References

    1. Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis 2013;4(57 suppl):S178–81. - PMC - PubMed
    1. Britt W. Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Medical microbiology and immunology 2015;204(3):263–71. - PubMed
    1. Alarcon A, et al. Clinical, biochemical, and neuroimaging findings predict long-term neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2013;163(3):828–34 e821. - PubMed
    1. Noyola DE, et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2001;138(3):325–31. - PubMed
    1. Pass RF, Stagno S, Britt WJ, Alford CA. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983;148(6):953–61. - PubMed

LinkOut - more resources